InVentis Technologies to Distribute TriLink Products in India
News Nov 07, 2014
TriLink BioTechnologies, Inc. has entered into a distribution agreement with inVentis Technologies, an Indian distribution and manufacturing company specializing in the life science and applied science, research, diagnostics and QC market. The agreement allows inVentis to market TriLink’s complete line of nucleic acid-based products. This includes TriLink’s stocked and custom nucleotides, oligonucleotides and mRNA, as well as their CleanAmp™ Hot Start PCR Products.
"With the biotech industry growing rapidly in India, TriLink has been looking for the right opportunity to enter the market. InVentis provides an extensive line of life science products to the biotech and pharmaceutical market and we feel that our high quality nucleic acid-based products will complement their offering and help advance research in the area,” commented TriLink's President and CEO, Richard Hogrefe, Ph.D.
“With the biotechnology industry in India increasingly focused on “OMICS”, InVentis has been looking for a world-class nucleic acid-based product line to fulfill the growing demand in the genomics and molecular biology sector. We anticipate that the market will continue to grow and addition of TriLink products will complement the portfolio offered by InVentis”, stated Founder and BM Singh, Sandeep. “We are delighted to enter into an agreement with TriLink.”
Innovative Chromatography Technologies to be Discussed at Preconference WorkshopNews
Biopharmaceutical researchers from around the globe will discuss innovative chromatographic approaches and technologies for purifying diverse biomolecules during a preconference workshop sponsored by Bio-Rad Laboratories, Inc.READ MORE
First Ever Online Event Focused on Cannabis ScienceNews
Analytical Cannabis is pleased to announce that the final line-up of speakers for the first ever cannabis science online event, The Science of Cannabis 2017 has been confirmed.READ MORE
Synpromics Announces Gene Therapy Research Partnership with Solid BiosciencesNews
Synpromics partner with Solid Biosciences ro develop treatment options Duchenne muscular dystrophy.READ MORE